Madrigal Pharmaceuticals (MDGL) EBT Margin (QoQ) (2010 - 2026)
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 14.93 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,396.00 |
| Mar 31, 2026 | -1,144.00 |
| Dec 31, 2025 | 2,048.00 |
| Sep 30, 2025 | -1,882.00 |
| Jun 30, 2025 | 3,350.00 |
| Mar 31, 2025 | 414.00 |
| Dec 31, 2024 | 11,453.00 |
| Sep 30, 2024 | 86,616.00 |
| Sep 30, 2012 | -1.02 Mn |
| Jun 30, 2012 | -994,558.00 |
| Mar 31, 2012 | -992,493.00 |
| Dec 31, 2011 | 45,142.00 |
| Sep 30, 2011 | 15,807.00 |
| Jun 30, 2011 | 7,412.00 |
| Mar 31, 2011 | -77,891.00 |
| Dec 31, 2010 | 8,479.00 |
| Sep 30, 2010 | -3,328.00 |